Company Snapshot
614 McKinley Place N.E.
Minneapolis, MN 55413
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 3,050
Please select from the dropdown
Company Financials

2020
2021
2022
Gross Profit
$483,194,000
$632,850,000
$756,496,000
Operating Income
$148,847,000
$242,690,000
$295,828,000
Net Income
$229,296,000
$140,410,000
$272,051,000
2020
Gross Profit
$483,194,000
Operating Income
$148,847,000
Net Income
$229,296,000
2021
Gross Profit
$632,850,000
Operating Income
$242,690,000
Net Income
$140,410,000
2022
Gross Profit
$756,496,000
Operating Income
$295,828,000
Net Income
$272,051,000
The above data on Bio-Techne Corp came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Director, President and Chief Executive Officer
$5,039,735
$10,299,361
$31,452
$15,370,548
$15,370,548
Director, President and Chief Executive Officer
Principal Accounting Officer, Executive Vice President and Chief Financial Officer
$1,926,340
$2,499,572
$10,117
$4,436,029
$4,436,029
Principal Accounting Officer, Executive Vice President and Chief Financial Officer
Executive Vice President General Counsel and Corporate Secretary
$1,449,260
$1,499,694
$9,272
$2,958,226
$2,958,226
Executive Vice President General Counsel and Corporate Secretary
President, Diagnostics and Genomics
$1,338,245
$1,599,820
$9,302
$2,947,367
$2,947,367
President, Diagnostics and Genomics
Chairman of the Board
$210,000
$199,833
$311
$410,144
Chairman of the Board
Bio-Techne Corp listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2022. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us